Subependymal giant cell astrocytoma pathophysiology
Subependymal giant cell astrocytoma Microchapters |
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Subependymal giant cell astrocytoma pathophysiology On the Web |
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma pathophysiology |
Subependymal giant cell astrocytoma pathophysiology in the news |
Blogs on Subependymal giant cell astrocytoma pathophysiology |
Risk calculators and risk factors for Subependymal giant cell astrocytoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Pathophysiology
Genetic
- Development of subependymal giant cell astrocytoma is the result of multiple genetic mutations.
- Genes involved in the pathogenesis of subependymal giant cell astrocytoma include:
Associated Conditions
Subependymal giant cell astrocytoma may be associated with tuberous sclerosis.[1]
Gross Pathology
- On gross pathology, subependymal giant cell astrocytoma is characterized by:
- Common intracranial sites associated with subependymal giant cell astrocytoma include:
Anatomical Location | Summary |
---|---|
Microscopic pathology
On microscopic histopathological analysis, subependymal giant cell astrocytoma is characterized by:
According to the WHO classification of tumors of the central nervous system, subependymal giant cell astrocytoma is classified into a WHO grade I tumor.
Immunohistochemistry
Subependymal giant cell astrocytoma is demonstrated by positivity to tumor markers such as:
Reference
- ↑ Associations of pilocytic astrocytoma. Dr Bruno Di Muzio and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pilocytic-astrocytoma. Accessed on October 26, 2015
- ↑ "Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age". Oncotarget. 2015. doi:10.18632/oncotarget.5571. ISSN 1949-2553.